News
Lauren Taylor speaks to Dr Jack Mosley – son of the late Michael Mosley – about weight-loss medication. Dr Jack Mosley: ...
Emmy Award-winning actor Eric Stonestreet, known for his portrayal of Cameron Tucker on ABC’s hit sitcom Modern Family, has revealed his private health journey with type 2 diabetes and how medication ...
Q, reporting significant increases in revenue and net income for the three months ended March 31, 2025. Revenue surged to $12 ...
Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...
8h
Pharmaceutical Technology on MSNLilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s WegovyEli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.
CVS said it will expand access to blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark.
As multiple large drugmakers look to navigate trade turbulence by pumping billions of dollars into their U.S. | Eli Lilly CEO ...
10h
Zacks Investment Research on MSNLLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock DownEli Lilly and Company LLY reported first-quarter 2025 adjusted earnings per share (“EPS”) of $3.34, which missed the Zacks ...
Katie Price has opened up about her son Harvey's struggle to manage his weight, revealing that she has spoken to doctors ...
Eli Lilly reported first-quarter revenue of $12.73 billion Thursday, a 45% increase from a year ago, driven by soaring demand ...
To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 ...
The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results